HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma

Summary

This is a study to use glucarpidase prophylactically to treat methotrexate induced toxicities in lymphoma patients with cerebral involvement.

Timeline

Start

2021-04-16

Primary completion

2024-12

Completion

2025-04

Outcome

Outcome not reported

Stopped (Enrollment): “To be terminated due to slow accrual, patient still in follow up”

Drugs

Indications